Roche's Cobas COVID Test Scores EUA For Asymptomatic People

Roche Holdings AG’s RHHBY Cobas SARS-CoV-2 Test has received U.S. authorization for testing individuals without symptoms or reasons to suspect a COVID-19 infection.
“The high-throughput, highly sensitive Cobas SARS-CoV-2 Test under FDA Emergency Use Authorization can now be used to test individual or pooled samples from people without symptoms or other reasons to suspect COVID-19,” Roche said in a statement.
The test applies to pooled samples containing up to and including six individual samples.
Price Action: RHHBY shares closed at $42.2 on Monday.